Synopsis. Penicillin administered for 10 days has been the treatment of cho
ice for group A beta-hemolytic streptococcal tonsillopharyngitis since the
1950s, The bacteriologic failure rate of 10 days of penicillin therapy rang
ed from approximately 2 to 10% until the early 1970s, Beginning in the late
1970s bacteriologic and clinical failure rates with penicillin therapy beg
an to increase steadily over time and are now reported to be approximately
30%, The primary cause of penicillin treatment failure in streptococcal ton
sillopharyngitis may be lack of compliance with the 10-day therapeutic regi
men. Other causes of penicillin treatment failure include reexposure to Str
eptococcus-infected family members or peers; copathogenicity, in which bact
eria susceptible to a class of drugs are protected by other, colocalized ba
cterial strains that lack the same susceptibility; antibiotic-associated er
adication of normal protective pharyngeal flora; and penicillin tolerance,
whereby streptococcal bacteria repeatedly or continuously exposed to sublet
hal concentrations of antibiotic become increasingly resistant to eradicati
on. Although 10 days of penicillin therapy is effective in the management o
f tonsillopharyngitis for many patients, multiple factors may, singly or to
gether, cause treatment failure. A number of antibiotics, particularly the
cephalosporins, have been demonstrated to be superior to penicillin at erad
icating group A beta-hemolytic Streptococcus, and several are effective whe
n administered for 4 to 5 days.
Conclusions. Ten days of penicillin therapy may not be the best therapeutic
choice for all pediatric patients. Other antibiotics, shortened courses of
the cephalosporins in particular, may be preferable in some cases.